Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,809 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
5-Fluorouracil, methotrexate, leucovorin, CDDP and epirubicin (FEPMTX): a wide-spectrum regimen of salvage chemotherapy for high-grade advanced gastric cancer.
Kinoshita K, Yonemura Y, Sawa T, Miyata T, Sakuma H, Matsuki N, Tanaka S, Fushida S, Fujimura T, Mok YJ, Kim BS, Lee JI, Choi DW, Song YJ, Yang DH, Kwon SJ, Tanaka M, Miyazaki I. Kinoshita K, et al. Among authors: kim bs. Hepatogastroenterology. 2003 Sep-Oct;50(53):1716-9. Hepatogastroenterology. 2003. PMID: 14571825
A phase II study of docetaxel as salvage chemotherapy in advanced gastric cancer after failure of fluoropyrimidine and platinum combination chemotherapy.
Lee JL, Ryu MH, Chang HM, Kim TW, Yook JH, Oh ST, Kim BS, Kim M, Chun YJ, Lee JS, Kang YK. Lee JL, et al. Among authors: kim bs, kim tw, kim m. Cancer Chemother Pharmacol. 2008 Apr;61(4):631-7. doi: 10.1007/s00280-007-0516-6. Epub 2007 May 23. Cancer Chemother Pharmacol. 2008. PMID: 17520252 Clinical Trial.
Phase II Study of Induction Chemotherapy with Docetaxel, Capecitabine, and Cisplatin Plus Bevacizumab for Initially Unresectable Gastric Cancer with Invasion of Adjacent Organs or Paraaortic Lymph Node Metastasis.
Kim JH, Park SR, Ryu MH, Ryoo BY, Kim KP, Kim BS, Yoo MW, Yook JH, Kim BS, Kim J, Byeon SJ, Kang YK. Kim JH, et al. Among authors: kim bs, kim kp, kim j. Cancer Res Treat. 2018 Apr;50(2):518-529. doi: 10.4143/crt.2017.005. Epub 2017 May 24. Cancer Res Treat. 2018. PMID: 28546521 Free PMC article. Clinical Trial.
A phase II study of irinotecan and docetaxel combination chemotherapy for patients with previously treated metastatic or recurrent advanced gastric cancer.
Sym SJ, Chang HM, Kang HJ, Lee SS, Ryu MH, Lee JL, Kim TW, Yook JH, Oh ST, Kim BS, Kang YK. Sym SJ, et al. Among authors: kim bs, kim tw. Cancer Chemother Pharmacol. 2008 Dec;63(1):1-8. doi: 10.1007/s00280-008-0701-2. Epub 2008 Feb 21. Cancer Chemother Pharmacol. 2008. PMID: 18288477 Clinical Trial.
4,809 results